Pharmaceutical News

RSS

Compounds related to curcumin receive U.S. patent

A U.S patent issued today to the University of Rochester and two other entities for the use of compounds related to a popular spice in the fight against cancer, acne, baldness, and other medical conditions.

13 Jun 2012

Telephone intervention improves medication adherence in patients with glaucoma

A telephone intervention trial was associated with improvement in glaucoma medication adherence in both the treatment group and the control group but, when the two groups were compared, interactive telephone calls and tailored print materials did not significantly improve adherence, according to a report of a randomized controlled clinical trial published Online First by Archives of Ophthalmology, a JAMA Network publication.

13 Jun 2012

Liquid glucagon formulation may be useable in standard diabetes pumps

JDRF-funded researchers at Oregon Health & Science University (OHSU) and Legacy Health have discovered a liquid glucagon formulation that may be useable in standard diabetes pumps.

13 Jun 2012

State roundup: N.Y.'s drug Rx bill passes unanimously, Mass. poll finds Dr. communication essential

New York lawmakers unanimously approved legislation Monday that will require doctors to issue drug prescriptions electronically within three years, meanwhile establishing tighter restrictions on painkillers and other addictive drugs on the state list of controlled substances.

13 Jun 2012

FDA grants Fast Track designation to Edimer’s EDI200 for treatment of XLHED

Edimer Pharmaceuticals, a biotechnology company focused on developing an innovative therapy for the rare genetic disorder, X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), today announced the receipt of Fast Track designation from the U.S. Food and Drug Administration (FDA) for EDI200, the company's novel, proprietary, recombinant protein.

13 Jun 2012

Experimental drug and genetic differences indicate how people deal with fear and stress

Researchers at Duke University and the National Institutes of Health have found a way to calm the fears of anxious mice with a drug that alters their brain chemistry. They've also found that human genetic differences related to the same brain chemistry influence how well people cope with fear and stress.

12 Jun 2012

New approach can design antibiotics that kill even 'superbugs'

The world needs new antibiotics to overcome the ever increasing resistance of disease-causing bacteria - but it doesn't need the side effect that comes with some of the most powerful ones now available: hearing loss. Today, researchers report they have developed a new approach to designing antibiotics that kill even "superbugs" but spare the delicate sensory cells of the inner ear.

12 Jun 2012

Normal p53 gene makes breast cancer chemotherapy with doxorubicin less effective

Presence of normal p53, a tumor suppressor gene, instead of a mutated version, makes breast cancer chemotherapy with doxorubicin less effective. The preclinical study led by MD Anderson scientists was published today in the journal Cancer Cell.

12 Jun 2012

Thiazolidinedione drugs linked with increased risk of DME in patients with Type 2 diabetes

Treatment with glucose-lowering thiazolidinedione drugs in patients with Type 2 diabetes appears to be associated with an increased risk of diabetic macular edema (a complication that may affect vision) at 1-year and 10-year follow-up evaluations, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication.

12 Jun 2012

China amends intellectual property laws to allow for issuance of compulsory licenses

"China has overhauled parts of its intellectual property laws to allow its drug makers to make cheap copies of medicines still under patent protection in an initiative likely to unnerve foreign pharmaceutical companies," Reuters reports.

12 Jun 2012

New set of computer models predicts negative side effects in current drugs

A new set of computer models has successfully predicted negative side effects in hundreds of current drugs, based on the similarity between their chemical structures and those molecules known to cause side effects, according to a paper appearing online this week in the journal Nature.

12 Jun 2012

Researchers demonstrate effectiveness of a potential new therapy for stroke patients

Researchers at the University of Missouri have demonstrated the effectiveness of a potential new therapy for stroke patients in an article published in the journal Molecular Neurodegeneration. Created to target a specific enzyme known to affect important brain functions, the new compound being studied at MU is designed to stop the spread of brain bleeds and protect brain cells from further damage in the crucial hours after a stroke.

12 Jun 2012

Genzyme files LEMTRADA sBLA and MAA with FDA, EMA for treatment of RMS

Genzyme, a Sanofi company, today announced that the company has submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) and a marketing authorization application (MAA) to the European Medicines Agency (EMA) seeking approval of LEMTRADA (alemtuzumab) for treatment of relapsing multiple sclerosis (RMS).

12 Jun 2012

Study shows how ruthenium-based drugs may be more effective at fighting cancer cells

A new study by University of Kentucky researchers shows how light and strained ruthenium-based drugs may be more effective at fighting cancer cells and less toxic to healthy cells than a similar and widely used drug.

12 Jun 2012

Sucrose and menthol act independently to reduce coughing

Millions of Americans reach for their cough drops or syrup at the first sign of a cough. However, scientists are unsure if and how these popular remedies work. Now, new findings from the Monell Center suggest that sucrose and menthol, ingredients commonly regarded as flavorings in these preparations, each act independently to reduce coughing.

12 Jun 2012

MVP receives European patent for PEG conjugates of interferon-beta-1b to treat MS

Mountain View Pharmaceuticals, Inc. announced its receipt of European Patent No. 1 667 708 B1, titled "Polyethylene Glycol Conjugates of Interferon-beta-1b with Enhanced in vitro Biological Potency."

12 Jun 2012

Rapid test to identify patients not responding to painkiller tramadol

French researchers have found a way to identify quickly the 5-10% of patients in whom the commonly used painkiller, tramadol, does not work effectively. A simple blood test can produce a result within a few hours, enabling doctors to switch a non-responding patient on to another painkiller, such as morphine, which will be able to work in these patients.

11 Jun 2012

Pharmaceutical News

Compounds related to curcumin receive U.S. patent

Telephone intervention improves medication adherence in patients with glaucoma

Liquid glucagon formulation may be useable in standard diabetes pumps

State roundup: N.Y.'s drug Rx bill passes unanimously, Mass. poll finds Dr. communication essential

FDA grants Fast Track designation to Edimer’s EDI200 for treatment of XLHED

Experimental drug and genetic differences indicate how people deal with fear and stress

New approach can design antibiotics that kill even 'superbugs'

Normal p53 gene makes breast cancer chemotherapy with doxorubicin less effective

Thiazolidinedione drugs linked with increased risk of DME in patients with Type 2 diabetes

China amends intellectual property laws to allow for issuance of compulsory licenses

New set of computer models predicts negative side effects in current drugs

Researchers demonstrate effectiveness of a potential new therapy for stroke patients

Genzyme files LEMTRADA sBLA and MAA with FDA, EMA for treatment of RMS

Study shows how ruthenium-based drugs may be more effective at fighting cancer cells

Sucrose and menthol act independently to reduce coughing

MVP receives European patent for PEG conjugates of interferon-beta-1b to treat MS

Rapid test to identify patients not responding to painkiller tramadol

Simple blood test can quickly identify 'poor metabolisers'

Republicans renew attack on 2009 Obama/drug industry deal for health law

Vitamin D deficiency may account for unexplained disparities in cancer survival rates

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News